{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:22:01Z","timestamp":1778844121451,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12010-021-03586-w","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T05:02:37Z","timestamp":1623042157000},"page":"3187-3201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Distribution of the Alpha-Synuclein in the Brain and the Primary Organs of the Rhesus Monkey"],"prefix":"10.1007","volume":"193","author":[{"given":"Jin-Ling","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Hong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Fu","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Kun","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"issue":"4","key":"3586_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/00019052-200108000-00001","volume":"14","author":"DW Dickson","year":"2001","unstructured":"Dickson, D. W. (2001). Alpha-synuclein and the Lewy body disorders. Current Opinion in Neurology, 14(4), 423\u2013432.","journal-title":"Current Opinion in Neurology"},{"issue":"4","key":"3586_CR2","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jchemneu.2010.12.001","volume":"42","author":"F Cheng","year":"2011","unstructured":"Cheng, F., Vivacqua, G., & Yu, S. (2011). The role of alpha-synuclein in neurotransmission and synaptic plasticity. Journal of Chemical Neuroanatomy, 42(4), 242\u2013248.","journal-title":"Journal of Chemical Neuroanatomy"},{"issue":"11","key":"3586_CR3","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998). Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proceedings of the National Academy of Sciences of the United States of America, 95(11), 6469\u20136473.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"3586_CR4","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba, M., Nakajo, S., Tu, P. H., Tomita, T., Nakaya, K., Lee, V. M., Trojanowski, J. Q., & Iwatsubo, T. (1998). Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. The American Journal of Pathology, 152(4), 879\u2013884.","journal-title":"The American Journal of Pathology"},{"issue":"Suppl 1","key":"3586_CR5","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.parkreldis.2015.08.015","volume":"22","author":"S Petrucci","year":"2016","unstructured":"Petrucci, S., Ginevrino, M., & Valente, E. M. (2016). Phenotypic spectrum of alpha-synuclein mutations: New insights from patients and cellular models. Parkinsonism & Related Disorders, 22(Suppl 1), S16\u2013S20.","journal-title":"Parkinsonism & Related Disorders"},{"key":"3586_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.neuropharm.2017.08.015","volume":"125","author":"N Katila","year":"2017","unstructured":"Katila, N., Bhurtel, S., Shadfar, S., Srivastav, S., Neupane, S., Ojha, U., Jeong, G. S., & Choi, D. Y. (2017). Metformin lowers alpha-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson\u2019s disease. Neuropharmacology., 125, 396\u2013407.","journal-title":"Neuropharmacology."},{"key":"3586_CR7","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.neuroscience.2018.03.026","volume":"379","author":"B Huang","year":"2018","unstructured":"Huang, B., Wu, S., Wang, Z., Ge, L., Rizak, J. D., Wu, J., Li, J., Xu, L., Lv, L., Yin, Y., Hu, X., & Li, H. (2018). Phosphorylated \u03b1-Synuclein accumulations and Lewy Body-like pathology distributed in Parkinson\u2019s disease-related brain areas of aged rhesus monkeys treated with MPTP. Neuroscience., 379, 302\u2013315.","journal-title":"Neuroscience."},{"key":"3586_CR8","doi-asserted-by":"crossref","unstructured":"Henrich, M. T., Geibl, F. F., Lee, B. et al. (2018). A53T-\u03b1-synuclein overexpression in murine locus coeruleus induces Parkinson\u2019s disease-like pathology in neurons and glia. Acta Neuropathologica Communications, 6(1).","DOI":"10.1186\/s40478-018-0541-1"},{"issue":"21","key":"3586_CR9","doi-asserted-by":"publisher","first-page":"8345","DOI":"10.1523\/JNEUROSCI.0772-15.2015","volume":"35","author":"W Yang","year":"2015","unstructured":"Yang, W., Wang, G., Wang, C. E., Guo, X., Yin, P., Gao, J., Tu, Z., Wang, Z., Wu, J., Hu, X., Li, S., & Li, X. J. (2015). Mutant alpha-synuclein causes age-dependent neuropathology in monkey brain. The Journal of Neuroscience, 35(21), 8345\u20138358.","journal-title":"The Journal of Neuroscience"},{"issue":"3","key":"3586_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4","volume":"45","author":"CF Lippa","year":"1999","unstructured":"Lippa, C. F., Schmidt, M. L., Lee, V. M., & Trojanowski, J. Q. (1999). Antibodies to alpha-synuclein detect Lewy bodies in many Down\u2019s syndrome brains with Alzheimer\u2019s disease. Annals of Neurology, 45(3), 353\u2013357.","journal-title":"Annals of Neurology"},{"issue":"4","key":"3586_CR11","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1750-3639.1999.tb00552.x","volume":"9","author":"M Hashimoto","year":"2010","unstructured":"Hashimoto, M., & Masliah, E. (2010). Alpha-synuclein in Lewy body disease and Alzheimer\u2019s disease. Brain Pathology, 9(4), 707\u2013720.","journal-title":"Brain Pathology"},{"issue":"2","key":"3586_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089327","volume":"9","author":"K Taguchi","year":"2014","unstructured":"Taguchi, K., Watanabe, Y., Tsujimura, A., Tatebe, H., Miyata, S., Tokuda, T., Mizuno, T., & Tanaka, M. (2014). Differential expression of alpha-synuclein in hippocampal neurons. PLoS One, 9(2), e89327.","journal-title":"PLoS One"},{"key":"3586_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2008.11.055","volume":"1251","author":"M Noguchi-Shinohara","year":"2009","unstructured":"Noguchi-Shinohara, M., Tokuda, T., Yoshita, M., Kasai, T., Ono, K., Nakagawa, M., el-Agnaf, O. M. A., & Yamada, M. (2009). CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer\u2019s disease. Brain Research, 1251, 1\u20136.","journal-title":"Brain Research"},{"issue":"47","key":"3586_CR14","doi-asserted-by":"publisher","first-page":"16906","DOI":"10.1523\/JNEUROSCI.2723-12.2012","volume":"32","author":"B Winner","year":"2012","unstructured":"Winner, B., Regensburger, M., Schreglmann, S., Boyer, L., Prots, I., Rockenstein, E., Mante, M., Zhao, C., Winkler, J., Masliah, E., & Gage, F. H. (2012). Role of -Synuclein in adult neurogenesis and neuronal maturation in the dentate gyrus. The Journal of Neuroscience, 32(47), 16906\u201316916.","journal-title":"The Journal of Neuroscience"},{"issue":"2","key":"3586_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H., Tredici, K. D., R\u00fcb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiology of Aging, 24(2), 197\u2013211.","journal-title":"Neurobiology of Aging"},{"key":"3586_CR16","unstructured":"Braak, H., & Del, T. K. (2009).Neuroanatomy and pathology of sporadic. Parkinson\u2019s Disease, 1\u2013119."},{"issue":"8","key":"3586_CR17","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/nn.3743","volume":"17","author":"P Calabresi","year":"2014","unstructured":"Calabresi, P., Picconi, B., Tozzi, A., Ghiglieri, V., & Di Filippo, M. (2014). Direct and indirect pathways of basal ganglia: a critical reappraisal. Nature Neuroscience, 17(8), 1022\u20131030.","journal-title":"Nature Neuroscience"},{"issue":"6","key":"3586_CR18","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/cne.23901","volume":"524","author":"K Taguchi","year":"2016","unstructured":"Taguchi, K., Watanabe, Y., Tsujimura, A., & Tanaka, M. (2016). Brain region-dependent differential expression of alpha-synuclein. The Journal of Comparative Neurology, 524(6), 1236\u20131258.","journal-title":"The Journal of Comparative Neurology"},{"issue":"3","key":"3586_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1385\/JMN:22:3:199","volume":"22","author":"S Ltic","year":"2004","unstructured":"Ltic, S., Perovic, M., Mladenovic, A., Raicevic, N., Ruzdijic, S., Rakic, L., & Kanazir, S. (2004). Alpha-synuclein is expressed in different tissues during human fetal development. Journal of Molecular Neuroscience, 22(3), 199\u2013204.","journal-title":"Journal of Molecular Neuroscience"},{"key":"3586_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jneumeth.2015.07.025","volume":"255","author":"SC Vermilyea","year":"2015","unstructured":"Vermilyea, S. C., & Emborg, M. E. (2015). alpha-Synuclein and nonhuman primate models of Parkinson\u2019s disease. Journal of Neuroscience Methods, 255, 38\u201351.","journal-title":"Journal of Neuroscience Methods"},{"issue":"1","key":"3586_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1477-7827-2-39","volume":"2","author":"AW Chan","year":"2004","unstructured":"Chan, A. W. (2004). Transgenic nonhuman primates for neurodegenerative diseases. Reproductive Biology and Endocrinology, 2(1), 39.","journal-title":"Reproductive Biology and Endocrinology"},{"key":"3586_CR22","doi-asserted-by":"crossref","unstructured":"Burm, S. M. (2014). Alternative methods for the use of non-human primates in biomedical research. ALTEX.","DOI":"10.14573\/altex.1406231"},{"issue":"1","key":"3586_CR23","first-page":"9","volume":"33","author":"J Hau","year":"2006","unstructured":"Hau, J., & Schapiro, S. J. (2006). Non-human primates in biomedical research. Scandinavian Journal of Laboratory Animal Science, 33(1), 9\u201312.","journal-title":"Scandinavian Journal of Laboratory Animal Science"},{"issue":"4","key":"3586_CR24","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3233\/JAD-131532","volume":"41","author":"M Yang","year":"2014","unstructured":"Yang, M., Miao, J., Rizak, J., Zhai, R., Wang, Z., Huma, T., Li, T., Zheng, N., Wu, S., Zheng, Y., Fan, X., Yang, J., Wang, J., Yang, S., Ma, Y., L\u00fc, L., He, R., & Hu, X. (2014). Alzheimer\u2019s disease and methanol toxicity (part 2): Lessons from four rhesus macaques (Macaca mulatta) chronically fed methanol. Journal of Alzheimer's Disease, 41(4), 1131\u20131147.","journal-title":"Journal of Alzheimer's Disease"},{"issue":"12","key":"3586_CR25","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/mt.2011.219","volume":"19","author":"JL McBride","year":"2011","unstructured":"McBride, J. L., Pitzer, M. R., Boudreau, R. L., et al. (2011). Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington\u2019s disease. Molecular Therapy, 19(12), 2152\u20132162.","journal-title":"Molecular Therapy"},{"key":"3586_CR26","unstructured":"Saleem, K. S. (2012). A combined MRI and histology atlas of the rhesus monkey brain in stereotaxic coordinates. Academic Press."},{"issue":"2","key":"3586_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12727","volume":"17","author":"R Rusconi","year":"2018","unstructured":"Rusconi, R., Ulusoy, A., Aboutalebi, H., & Di Monte, D. A. (2018). Long-lasting pathological consequences of overexpression-induced \u03b1-synuclein spreading in the rat brain. Aging Cell, 17(2), e12727.","journal-title":"Aging Cell"},{"issue":"2","key":"3586_CR28","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.toxlet.2005.08.010","volume":"161","author":"K Malkiewicz","year":"2006","unstructured":"Malkiewicz, K., Mohammed, R., Folkesson, R., Winblad, B., Szutowski, M., & Benedikz, E. (2006). Polychlorinated biphenyls alter expression of \u03b1-synuclein, synaptophysin and parkin in the rat brain. Toxicology Letters, 161(2), 152\u2013158.","journal-title":"Toxicology Letters"},{"issue":"1-2","key":"3586_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S0006-8993(02)02643-4","volume":"941","author":"F Mori","year":"2002","unstructured":"Mori, F., Tanji, K., Yoshimoto, M., Takahashi, H., & Wakabayashi, K. (2002). Immunohistochemical comparison of alpha- and beta-synuclein in adult rat central nervous system. Brain Research, 941(1-2), 118\u2013126.","journal-title":"Brain Research"},{"issue":"3","key":"3586_CR30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10571-009-9473-4","volume":"30","author":"S Zhong","year":"2010","unstructured":"Zhong, S., Luo, X., Chen, X., Cai, Q. Y., Liu, J., Chen, X. H., & Yao, Z. X. (2010). Expression and subcellular location of alpha-synuclein during mouse-embryonic development. Cellular and Molecular Neurobiology, 30(3), 469\u2013482.","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"4","key":"3586_CR31","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.neuroscience.2008.12.001","volume":"158","author":"G Vivacqua","year":"2009","unstructured":"Vivacqua, G., Yin, J. J., Casini, A., Li, X., Li, Y. H., D'Este, L., Chan, P., Renda, T. G., & Yu, S. (2009). Immunolocalization of alpha-synuclein in the rat spinal cord by two novel monoclonal antibodies. Neuroscience., 158(4), 1478\u20131487.","journal-title":"Neuroscience."},{"issue":"3","key":"3586_CR32","first-page":"a024091","volume":"8","author":"J Burr\u00e9","year":"2018","unstructured":"Burr\u00e9, J., Sharma, M., & S\u00fcdhof, T. C. (2018). Cell biology and pathophysiology of \u03b1-synuclein. CSH Perspectives in Medicine, 8(3), a024091.","journal-title":"CSH Perspectives in Medicine"},{"issue":"5456","key":"3586_CR33","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","volume":"287","author":"E Masliah","year":"2000","unstructured":"Masliah, E. (2000). Dopaminergic loss and inclusion body formation in -synuclein mice: implications for neurodegenerative disorders. Science., 287(5456), 1265\u20131269.","journal-title":"Science."},{"issue":"30","key":"3586_CR34","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.0535-12.2012","volume":"32","author":"D Scott","year":"2012","unstructured":"Scott, D., & Roy, S. (2012). Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis. The Journal of Neuroscience, 32(30), 10129\u201310135.","journal-title":"The Journal of Neuroscience"},{"issue":"7","key":"3586_CR35","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","volume":"22","author":"D Kirik","year":"2002","unstructured":"Kirik, D., Rosenblad, C., Burger, C., Lundberg, C., Johansen, T. E., Muzyczka, N., Mandel, R. J., & Bj\u00f6rklund, A. (2002). Parkinson-like neurodegeneration induced by targeted overexpression of \u03b1-synuclein in the nigrostriatal system. The Journal of Neuroscience., 22(7), 2780\u20132791.","journal-title":"The Journal of Neuroscience."},{"issue":"32","key":"3586_CR36","doi-asserted-by":"publisher","first-page":"13112","DOI":"10.1073\/pnas.1210833109","volume":"109","author":"YB Dai","year":"2012","unstructured":"Dai, Y. B., Tan, X. J., Wu, W. F., Warner, M., & Gustafsson, J. A. (2012). Liver X receptor protects dopaminergic neurons in a mouse model of Parkinson disease. Proceedings of the National Academy of Sciences, 109(32), 13112\u201313117.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"3586_CR37","doi-asserted-by":"crossref","unstructured":"Gonzalo-Gobernado R. (2013). CLRD. Neuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson\u2019s Disease. Plos One.","DOI":"10.1371\/journal.pone.0067771"},{"key":"3586_CR38","unstructured":"Hong, L. Z. W. T. (2010). Clinical Trial of Ping-Chan-Jie-Yu Decoction on depression in Parkinson disease with liver and kidney yin deficiency. Liaoning Journal of traditional Chinese Medicine."}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-021-03586-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-021-03586-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-021-03586-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T05:39:37Z","timestamp":1632807577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-021-03586-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["3586"],"URL":"https:\/\/doi.org\/10.1007\/s12010-021-03586-w","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,7]]},"assertion":[{"value":"4 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Experimental Animal Ethics Committee of the Institute of Medical Biology Chinese Academy of Medical Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Animals Participants"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}